Comments and Reflections on Ethics in Screening for Biomarkers of Prenatal Alcohol Exposure
- 2 April 2013
- journal article
- review article
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 37 (9) , 1451-1455
Abstract
Early identification of and intervention for fetal alcohol spectrum disorder (FASD) has been shown to optimize outcomes for affected individuals. Detecting biomarkers of prenatal alcohol exposure (PAE) in neonates may assist in the identification of children at risk of FASD enabling targeted early interventions. Despite these potential benefits, complicated ethical issues arise in screening for biomarkers of PAE and these must be addressed prior to the implementation of screening programs. Here, we identify and comment, based on a North American perspective, on concerns raised in the current ethical, social, and legal literature related to meconium screening for PAE. Major ethical concerns revolve around the targeting of populations for PAE screening, consent and respect for persons, stigma and participation rates, the cost-benefit analysis of a screening program, consequences of false-positive and false-negative test results, confidentiality and appropriate follow-up to positive screen results, and the use of screen results for criminal prosecution. We identify gaps in the literature on screening for PAE, most notably related to a lack of stakeholder perspectives (e.g., parents, healthcare providers) about screening and the ethical challenges it presents.Keywords
This publication has 18 references indexed in Scilit:
- Assessment of benefits of a universal screen for maternal alcohol use during pregnancyBirth Defects Research Part A: Clinical and Molecular Teratology, 2010
- Alcohol and Drug Screening of Newborns: Would Women Consent?Journal of Obstetrics and Gynaecology Canada, 2009
- Universal or Targeted Screening for Fetal Alcohol Exposure: A Cost-Effectiveness AnalysisJournal of Studies on Alcohol and Drugs, 2008
- Prevalence of Fetal Ethanol Exposure in a Regional Population-Based Sample by Meconium Analysis of Fatty Acid Ethyl EstersTherapeutic Drug Monitoring, 2008
- Novel approaches to the diagnosis of fetal alcohol spectrum disorderNeuroscience & Biobehavioral Reviews, 2007
- Drug and alcohol use during pregnancy: We need to protect, not punish, womenWomen's Health Issues, 2005
- Fetal alcohol spectrum disorder: Canadian guidelines for diagnosisCanadian Medical Association Journal, 2005
- Physician attitudes concerning legal coercion of pregnant alcohol and drug abusersAmerican Journal of Obstetrics and Gynecology, 2002
- Drug Screening and Criminal Prosecution of Pregnant WomenJournal of Obstetric, Gynecologic, & Neonatal Nursing, 2002
- Diagnosing moral disorder: the discovery and evolution of fetal alcohol syndromeSocial Science & Medicine, 1998